BDH Industries Limited (BDH INDUSTRIES LTD.) aksje

BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally. The company operates through two segments, Pharmaceuticals and Renewable Energy segments. It provides analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, and antiulcers pharmaceutical products. The company also offers antivirals, sedatives/anxiolytics/antidepressants, calcium supplements, cardiovascular products, carminatives/aromatics, corticosteroids, diuretics, drugs acting on uterus, electrolyte replinishers, expextorants, iron supplements, laxatives, local anesthetics, general anesthetics, mydriatics, narcotic-analgesics, non-steroidal anti-inflammatory products, rubefacient and mild analgesics, and pharmaceutical aid products. In addition, it provides skin protectives, skin smoothners, and vitamins, as well as SOULFIL, an oral pill for the treatment of erectile dysfunction in men. Further, the company is involved in the operation in renewable energy through two wind turbines with a total capacity of 0.8 MW located at Jaisalmer, Rajasthan. BDH Industries Limited was founded in 1935 and is based in Mumbai, India.